Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionNtv Asset Management Llc
Latest Disclosed Ownership23,625 shares
Latest Disclosed Value $ 1,432,856
Ntv Asset Management Llc reports 3.60% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 28, 2026 - Ntv Asset Management Llc filed a 13F-HR form disclosing ownership of 23,625 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,238,422 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 22,805 shares of Bristol-Myers Squibb Company. This represents a change in shares of 3.60% during the quarter. The current value of the position is $1,120,534 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F Bristol Myers Squibb COM 110122108 23,625 820 3.60 1,433 16.42 0.1575
2026-01-20 2025-12-31 13F Bristol Myers Squibb COM 110122108 22,805 -3,250 -12.47 1,230 4.68 0.1303
2025-10-21 2025-09-30 13F Bristol Myers Squibb COM 110122108 26,055 -4,189 -13.85 1,175 -16.01 0.1281
2025-07-21 2025-06-30 13F Bristol Myers Squibb COM 110122108 30,244 -1,300 -4.12 1,400 -27.25 0.1673
2025-04-30 2025-03-31 13F Bristol Myers Squibb COM 110122108 31,544 -1,000 -3.07 1,924 4.51 0.2563
2025-01-31 2024-12-31 13F Bristol Myers Squibb COM 110122108 32,544 -149 -0.46 1,841 8.81 0.2427
2024-10-31 2024-09-30 13F Bristol Myers Squibb COM 110122108 32,693 -774 -2.31 1,692 21.74 0.2262
2024-07-31 2024-06-30 13F Bristol Myers Squibb COM 110122108 33,467 -239 -0.71 1,390 -23.97 0.1989
2024-05-07 2024-03-31 13F Bristol Myers Squibb COM 110122108 33,706 2,884 9.36 1,828 15.56 0.2786
2024-02-06 2023-12-31 13F Bristol Myers Squibb COM 110122108 30,822 -1,502 -4.65 1,581 -15.72 0.2664
2023-11-06 2023-09-30 13F Bristol Myers Squibb COM 110122108 32,324 -1,300 -3.87 1,876 -12.74 0.3399
2023-08-02 2023-06-30 13F Bristol Myers Squibb COM 110122108 33,624 0 0.00 2,150 -7.73 0.3750
2023-05-05 2023-03-31 13F Bristol Myers Squibb COM 110122108 33,624 0 0.00 2,330 -3.68 0.4336
2023-02-08 2022-12-31 13F Bristol Myers Squibb COM 110122108 33,624 300 0.90 2,419 2.11 0.4752
2022-11-07 2022-09-30 13F Bristol Myers Squibb COM 110122108 33,324 -500 -1.48 2,369 -9.02 0.4982
2022-07-28 2022-06-30 13F Bristol-Myers Squibb COM 110122108 33,824 733 2.22 2,604 7.74 0.5093
2022-05-06 2022-03-31 13F Bristol Myers Squibb COM 110122108 33,091 1,799 5.75 2,417 23.89 0.4053
2022-02-04 2021-12-31 13F Bristol-Myers Squibb COM 110122108 31,292 700 2.29 1,951 7.79 0.3237
2021-11-10 2021-09-30 13F Bristol Myers Squibb COM 110122108 30,592 500 1.66 1,810 -10.00 0.3143
2021-08-09 2021-06-30 13F Bristol Myers Squibb COM 110122108 30,092 -350 -1.15 2,011 4.63 0.3556
2021-05-10 2021-03-31 13F Bristol-Myers Squibb COM 110122108 30,442 717 2.41 1,922 4.23 0.3557
2021-02-05 2020-12-31 13F Bristol-Myers Squibb COM 110122108 29,725 -600 -1.98 1,844 0.88 0.3709
2020-10-29 2020-09-30 13F Bristol Myers Squibb COM 110122108 30,325 -100 -0.33 1,828 2.18 0.4341
2020-08-07 2020-06-30 13F Bristol-Myers Squibb COM 110122108 30,425 1,700 5.92 1,789 11.74 0.4630
2020-05-06 2020-03-31 13F Bristol Myers Squibb COM 110122108 28,725 -342 -1.18 1,601 -14.20 0.5259
2020-01-30 2019-12-31 13F Bristol Myers Squibb COM 110122108 29,067 700 2.47 1,866 29.76 0.4754
2019-11-04 2019-09-30 13F Bristol Myers Squibb COM 110122108 28,367 -1,200 -4.06 1,438 7.23 0.4094
2019-07-29 2019-06-30 13F Bristol Myers Squibb COM 110122108 29,567 -1,550 -4.98 1,341 -9.70 0.3848
2019-04-29 2019-03-31 13F Bristol Myers Squibb COM 110122108 31,117 300 0.97 1,485 -7.30 0.4238
2019-01-28 2018-12-31 13F Bristol Myers Squibb COM 110122108 30,817 -1,950 -5.95 1,602 -21.24 0.5191
2018-11-08 2018-09-30 13F Bristol Myers Squibb COM 110122108 32,767 0 0.00 2,034 12.19 0.5494
2018-08-06 2018-06-30 13F Bristol Myers Squibb COM 110122108 32,767 -2,300 -6.56 1,813 -18.26 0.5105
2018-05-04 2018-03-31 13F Bristol Myers Squibb Com 110122108 35,067 -400 -1.13 2,218 2.07 0.6296
2018-02-06 2017-12-31 13F Bristol Myers Squibb Com 110122108 35,467 -200 -0.56 2,173 -4.40 0.6050
2017-11-06 2017-09-30 13F Bristol Myers Squibb Com 110122108 35,667 -1,150 -3.12 2,273 10.82 0.6592
2017-08-08 2017-06-30 13F Bristol Myers Squibb Com 110122108 36,817 800 2.22 2,051 4.75 0.6249
2017-05-03 2017-03-31 13F Bristol Myers Squibb Com 110122108 36,017 500 1.41 1,958 -5.64 0.6205
2017-02-14 2016-12-31 13F Bristol Myers Squibb Com 110122108 35,517 0 0.00 2,075 8.36 0.7163
2016-11-08 2016-09-30 13F Bristol Myers Squibb Com 110122108 35,517 7,700 27.68 1,915 -6.36 0.6904
2016-08-08 2016-06-30 13F Bristol Myers Squibb Com 110122108 27,817 -250 -0.89 2,045 14.12 0.7747
2016-05-02 2016-03-31 13F Bristol Myers Squibb Com 110122108 28,067 0 0.00 1,792 -7.15 0.6879
2016-02-02 2015-12-31 13F Bristol Myers Squibb Com 110122108 28,067 -7,000 -19.96 1,930 -6.99 0.7615
2015-11-05 2015-09-30 13F Bristol Myers Squibb Com 110122108 35,067 -200 -0.57 2,075 -11.55 0.6742
2015-08-05 2015-06-30 13F Bristol Myers Squibb Com 110122108 35,267 -450 -1.26 2,346 1.87 0.6881
2015-05-05 2015-03-31 13F Bristol Myers Squibb Com 110122108 35,717 -250 -0.70 2,303 8.48 0.6858
2015-02-23 2014-12-31 13F Bristol Myers Squibb Com 110122108 35,967 -1,200 -3.23 2,123 11.62 0.6286
2014-10-31 2014-09-30 13F Bristol Myers Squibb Com 110122108 37,167 0 0.00 1,902 5.55 0.5767
2014-07-31 2014-06-30 13F Bristol Myers Squibb Com 110122108 37,167 -350 -0.93 1,802 -7.54 0.5465
2014-05-05 2014-03-31 13F Bristol Myers Squibb Com 110122108 37,517 0 0.00 1,949 -2.26 0.6247
2014-02-11 2013-12-31 13F Bristol Myers Squibb Com 110122108 37,517 0 0.00 1,994 14.86 0.6766
2013-11-07 2013-09-30 13F Bristol Myers Squibb Com 110122108 37,517 -7,550 -16.75 1,736 -13.80 0.6085
2013-08-08 2013-06-30 13F Bristol Myers Squibb Com 110122108 45,067 45,067 2,014 0.7314
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.